{"transactions":[{"id":708536,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2026-07-16T20:18:18.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":40,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $109.88. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment."}],"balance_after":22972,"source":{"system":"sec-edgar","filing":"0000785161-26-000174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000078516126000174/form4.xml","form_type":"4"}},{"id":785822,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2026-05-11T15:31:02.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":1634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual grant of restricted stock units pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan."}],"balance_after":22932,"source":{"system":"sec-edgar","filing":"0000785161-26-000132","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000078516126000132/form4.xml","form_type":"4"}},{"id":789340,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $1 par value","published_at":"2026-05-07T20:20:12.000Z","date":"2026-05-05","kind":"grant","planned":false,"acquired":true,"shares":12836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total includes the automatic reinvestment of dividends."}],"balance_after":34994,"source":{"system":"sec-edgar","filing":"0001628280-26-032184","document":"wk-form4_1778185209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10456/000162828026032184/wk-form4_1778185209.xml","form_type":"4"}},{"id":807707,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2026-04-16T18:40:35.000Z","date":"2026-04-15","kind":"grant","planned":false,"acquired":true,"shares":39,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $105.24. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":21298,"source":{"system":"sec-edgar","filing":"0000785161-26-000111","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000078516126000111/form4.xml","form_type":"4"}},{"id":937928,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2026-01-16T21:21:15.000Z","date":"2026-01-15","kind":"grant","planned":false,"acquired":true,"shares":40,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $102.80. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":21259,"source":{"system":"sec-edgar","filing":"0000785161-26-000008","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000078516126000008/form4.xml","form_type":"4"}},{"id":1018020,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2025-10-16T19:36:31.000Z","date":"2025-10-15","kind":"grant","planned":false,"acquired":true,"shares":33,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2025, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $123.65. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":21219,"source":{"system":"sec-edgar","filing":"0000785161-25-000098","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000078516125000098/form4.xml","form_type":"4"}},{"id":1065297,"issuer":{"id":16467,"kind":"organization","name":"Walgreens Boots Alliance, Inc.","symbol":"WBA"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-15T17:59:56.000Z","date":"2025-08-13","kind":"grant","planned":false,"acquired":true,"shares":16820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Annual share grant issued as non-employee director compensation under the Amended and Restated Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan in arrears with respect to services rendered over the course of the prior year."}],"balance_after":37961,"source":{"system":"sec-edgar","filing":"0001618921-25-000077","document":"wk-form4_1755295192.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618921/000161892125000077/wk-form4_1755295192.xml","form_type":"4"}},{"id":1087041,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2025-07-16T18:17:59.000Z","date":"2025-07-15","kind":"grant","planned":false,"acquired":true,"shares":34,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2025, Encompass Health paid a dividend on its common stock of $0.17 per share and the closing price was $107.28. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":21186,"source":{"system":"sec-edgar","filing":"0001127602-25-019255","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760225019255/form4.xml","form_type":"4"}},{"id":1155843,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $1 par value","published_at":"2025-05-08T20:27:39.000Z","date":"2025-05-06","kind":"grant","planned":false,"acquired":true,"shares":7183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total includes the automatic reinvestment of dividends."}],"balance_after":21850,"source":{"system":"sec-edgar","filing":"0001062993-25-008902","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10456/000106299325008902/form4.xml","form_type":"4"}},{"id":1161930,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2025-05-02T18:24:59.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":1424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual grant of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan."}],"balance_after":21152,"source":{"system":"sec-edgar","filing":"0001127602-25-013121","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760225013121/form4.xml","form_type":"4"}},{"id":1171352,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2025-04-16T20:48:43.000Z","date":"2025-04-15","kind":"grant","planned":false,"acquired":true,"shares":33,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2025, Encompass Health paid a dividend on its common stock of $0.17 per share and the closing price was $102.30. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":19728,"source":{"system":"sec-edgar","filing":"0001127602-25-012145","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760225012145/form4.xml","form_type":"4"}},{"id":1301089,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2025-01-17T19:55:33.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":36,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2025, Encompass Health paid a dividend on its common stock of $0.17 per share and the closing price was $93.61. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":19695,"source":{"system":"sec-edgar","filing":"0001127602-25-001418","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760225001418/form4.xml","form_type":"4"}},{"id":1375406,"issuer":{"id":16467,"kind":"organization","name":"Walgreens Boots Alliance, Inc.","symbol":"WBA"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-05T20:57:47.000Z","date":"2024-11-01","kind":"grant","planned":false,"acquired":true,"shares":21141,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (including the applicable election forms thereunder)."}],"balance_after":21141,"source":{"system":"sec-edgar","filing":"0001618921-24-000129","document":"wk-form4_1730858260.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618921/000161892124000129/wk-form4_1730858260.xml","form_type":"4"}},{"id":1385433,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2024-10-17T17:16:18.000Z","date":"2024-10-15","kind":"grant","planned":false,"acquired":true,"shares":35,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2024, Encompass Health paid a dividend on its common stock of $0.17 per share and the closing price was $96.33. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":19659,"source":{"system":"sec-edgar","filing":"0001127602-24-025666","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760224025666/form4.xml","form_type":"4"}},{"id":1453289,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2024-07-17T20:15:41.000Z","date":"2024-07-15","kind":"grant","planned":false,"acquired":true,"shares":35,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2024, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $85.49. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":19624,"source":{"system":"sec-edgar","filing":"0001127602-24-020574","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760224020574/form4.xml","form_type":"4"}},{"id":1522893,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $1 par value","published_at":"2024-05-09T20:34:23.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":5952,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total includes the automatic reinvestment of dividends."}],"balance_after":14278,"source":{"system":"sec-edgar","filing":"0001062993-24-009784","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10456/000106299324009784/form4.xml","form_type":"4"}},{"id":1529672,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2024-05-03T17:16:30.000Z","date":"2024-05-02","kind":"grant","planned":false,"acquired":true,"shares":1978,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual grant of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan."}],"balance_after":19589,"source":{"system":"sec-edgar","filing":"0001127602-24-014081","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760224014081/form4.xml","form_type":"4"}},{"id":1541640,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2024-04-16T21:01:55.000Z","date":"2024-04-15","kind":"grant","planned":false,"acquired":true,"shares":33,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2024, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $80.73. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":17611,"source":{"system":"sec-edgar","filing":"0001127602-24-013019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760224013019/form4.xml","form_type":"4"}},{"id":1676364,"issuer":{"id":16467,"kind":"organization","name":"Walgreens Boots Alliance, Inc.","symbol":"WBA"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-18T16:18:42.000Z","date":"2024-01-16","kind":"sale","planned":false,"acquired":false,"shares":15209,"price":23.05,"value":350567.45,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001618921-24-000008","document":"wk-form4_1705612712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618921/000161892124000008/wk-form4_1705612712.xml","form_type":"4"}},{"id":1678693,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2024-01-17T20:28:08.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":37,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 16, 2024, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $71.45. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":17578,"source":{"system":"sec-edgar","filing":"0001127602-24-001399","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760224001399/form4.xml","form_type":"4"}},{"id":1749769,"issuer":{"id":16467,"kind":"organization","name":"Walgreens Boots Alliance, Inc.","symbol":"WBA"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-03T19:18:17.000Z","date":"2023-11-01","kind":"grant","planned":false,"acquired":true,"shares":9694,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan (including the applicable election forms thereunder)."}],"balance_after":15209,"source":{"system":"sec-edgar","filing":"0001618921-23-000090","document":"wk-form4_1699053485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618921/000161892123000090/wk-form4_1699053485.xml","form_type":"4"}},{"id":1759485,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2023-10-17T21:24:06.000Z","date":"2023-10-16","kind":"grant","planned":false,"acquired":true,"shares":42,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 16, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $63.77. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":17541,"source":{"system":"sec-edgar","filing":"0001127602-23-026021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760223026021/form4.xml","form_type":"4"}},{"id":1828282,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2023-07-18T18:00:46.000Z","date":"2023-07-17","kind":"grant","planned":false,"acquired":true,"shares":39,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 17, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $67.54. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":17499,"source":{"system":"sec-edgar","filing":"0001127602-23-020915","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760223020915/form4.xml","form_type":"4"}},{"id":1901688,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2023-05-08T16:55:30.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":2385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual grant of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan."}],"balance_after":17460,"source":{"system":"sec-edgar","filing":"0001127602-23-014805","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760223014805/form4.xml","form_type":"4"}},{"id":1905385,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $1 par value","published_at":"2023-05-04T20:34:40.000Z","date":"2023-05-02","kind":"grant","planned":false,"acquired":true,"shares":4573,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant."}],"balance_after":8099,"source":{"system":"sec-edgar","filing":"0001062993-23-010211","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10456/000106299323010211/form4.xml","form_type":"4"}},{"id":1917649,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2023-04-19T17:16:04.000Z","date":"2023-04-17","kind":"grant","planned":false,"acquired":true,"shares":37,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 17, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $61.39. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":15075,"source":{"system":"sec-edgar","filing":"0001127602-23-013204","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760223013204/form4.xml","form_type":"4"}},{"id":2007241,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-17T21:11:50.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":66666,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":66666,"source":{"system":"sec-edgar","filing":"0001062993-23-004036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376358/000106299323004036/form4.xml","form_type":"4"}},{"id":2051686,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2023-01-19T16:50:12.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":37,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 17, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $61.16. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":15038,"source":{"system":"sec-edgar","filing":"0001127602-23-001749","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760223001749/form4.xml","form_type":"4"}},{"id":2108538,"issuer":{"id":16467,"kind":"organization","name":"Walgreens Boots Alliance, Inc.","symbol":"WBA"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-21T18:11:37.000Z","date":"2022-11-17","kind":"sale","acquired":false,"shares":16570,"price":39.887,"value":660927.59,"ownership":{"direct":true},"balance_after":5515,"source":{"system":"sec-edgar","filing":"0001618921-22-000095","document":"wf-form4_166907227504727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618921/000161892122000095/wf-form4_166907227504727.xml","form_type":"4"}},{"id":2125577,"issuer":{"id":16467,"kind":"organization","name":"Walgreens Boots Alliance, Inc.","symbol":"WBA"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-03T19:13:15.000Z","date":"2022-11-01","kind":"grant","acquired":true,"shares":5515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan."}],"balance_after":22085,"source":{"system":"sec-edgar","filing":"0001618921-22-000075","document":"wf-form4_166751718079532.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618921/000161892122000075/wf-form4_166751718079532.xml","form_type":"4"}},{"id":2135153,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2022-10-19T15:13:01.000Z","date":"2022-10-17","kind":"grant","acquired":true,"shares":46,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 17, 2022, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $48.81. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":15001,"source":{"system":"sec-edgar","filing":"0001127602-22-024122","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760222024122/form4.xml","form_type":"4"}},{"id":2204226,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2022-07-21T21:12:32.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":85,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 20, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $49.19. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":12432,"source":{"system":"sec-edgar","filing":"0001127602-22-019605","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760222019605/form4.xml","form_type":"4"}},{"id":2229837,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-16T20:12:57.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of PEAR common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest and settle as to 100% of the shares upon the Reporting Person's cessation of Service Relationship (as defined in the Issuer's 2021 Stock Option and Incentive Plan) that qualifies as a \"separation from service\" within the meaning of Section 409A of the Internal Revenue Code (the \"Separation Date\"), provided that the Separation Date occurs on or after June 14, 2023 (and for the avoidance of doubt, if the Separation Date occurs prior to June 14, 2023, the restricted stock units shall expire unvested)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest and settle as to 100% of the shares upon the Reporting Person's cessation of Service Relationship (as defined in the Issuer's 2021 Stock Option and Incentive Plan) that qualifies as a \"separation from service\" within the meaning of Section 409A of the Internal Revenue Code (the \"Separation Date\"), provided that the Separation Date occurs on or after June 14, 2023 (and for the avoidance of doubt, if the Separation Date occurs prior to June 14, 2023, the restricted stock units shall expire unvested)."}],"balance_after":100000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001062993-22-014977","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376358/000106299322014977/form4.xml","form_type":"4"}},{"id":2278539,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2022-05-09T20:21:32.000Z","date":"2022-05-05","kind":"grant","acquired":true,"shares":2226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual grant of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan."}],"balance_after":12347,"source":{"system":"sec-edgar","filing":"0001127602-22-013836","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760222013836/form4.xml","form_type":"4"}},{"id":2281639,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $1 par value","published_at":"2022-05-05T21:25:39.000Z","date":"2022-05-03","kind":"grant","acquired":true,"shares":2706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received a grant of fully vested shares of common stock of Baxter International Inc., subject to the terms and conditions of the applicable grant."}],"balance_after":3451,"source":{"system":"sec-edgar","filing":"0001062993-22-011690","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10456/000106299322011690/form4.xml","form_type":"4"}},{"id":2294312,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2022-04-20T18:04:33.000Z","date":"2022-04-18","kind":"grant","acquired":true,"shares":40,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $71.41. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":10121,"source":{"system":"sec-edgar","filing":"0001127602-22-012253","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760222012253/form4.xml","form_type":"4"}},{"id":2431589,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2022-01-20T22:16:08.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":46,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $61.63. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":10081,"source":{"system":"sec-edgar","filing":"0001127602-22-001736","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760222001736/form4.xml","form_type":"4"}},{"id":2472699,"issuer":{"id":132395,"kind":"organization","name":"Hill-Rom Holdings, Inc.","symbol":"HRC"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (03/11/2021)","published_at":"2021-12-15T20:40:55.000Z","date":"2021-12-13","kind":"disposition_to_issuer","acquired":false,"shares":1798,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. (\"Baxter\"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. (\"Baxter\"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. (\"Baxter\"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1798},"source":{"system":"sec-edgar","filing":"0001214659-21-013220","document":"marketforms-54639.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/47518/000121465921013220/marketforms-54639.xml","form_type":"4"}},{"id":2472698,"issuer":{"id":132395,"kind":"organization","name":"Hill-Rom Holdings, Inc.","symbol":"HRC"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (02/26/2020)","published_at":"2021-12-15T20:40:55.000Z","date":"2021-12-13","kind":"disposition_to_issuer","acquired":false,"shares":1870,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. (\"Baxter\"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. (\"Baxter\"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. (\"Baxter\"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1870},"source":{"system":"sec-edgar","filing":"0001214659-21-013220","document":"marketforms-54639.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/47518/000121465921013220/marketforms-54639.xml","form_type":"4"}},{"id":2472697,"issuer":{"id":132395,"kind":"organization","name":"Hill-Rom Holdings, Inc.","symbol":"HRC"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (03/06/2019)","published_at":"2021-12-15T20:40:55.000Z","date":"2021-12-13","kind":"disposition_to_issuer","acquired":false,"shares":1762,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. (\"Baxter\"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. (\"Baxter\"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. (\"Baxter\"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1762},"source":{"system":"sec-edgar","filing":"0001214659-21-013220","document":"marketforms-54639.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/47518/000121465921013220/marketforms-54639.xml","form_type":"4"}},{"id":2472696,"issuer":{"id":132395,"kind":"organization","name":"Hill-Rom Holdings, Inc.","symbol":"HRC"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (03/07/2018)","published_at":"2021-12-15T20:40:55.000Z","date":"2021-12-13","kind":"disposition_to_issuer","acquired":false,"shares":2184,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. (\"Baxter\"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. (\"Baxter\"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. (\"Baxter\"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2184},"source":{"system":"sec-edgar","filing":"0001214659-21-013220","document":"marketforms-54639.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/47518/000121465921013220/marketforms-54639.xml","form_type":"4"}},{"id":2472695,"issuer":{"id":132395,"kind":"organization","name":"Hill-Rom Holdings, Inc.","symbol":"HRC"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (03/14/2017)","published_at":"2021-12-15T20:40:55.000Z","date":"2021-12-13","kind":"disposition_to_issuer","acquired":false,"shares":2762,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. (\"Baxter\"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. (\"Baxter\"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. (\"Baxter\"), and a wholly-owned subsidiary of Baxter, these restricted stock units, which provided for vesting on the date of grant, with delivery of the underlying shares of common stock not occurring until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the director ceases to be a member of the Board of Directors of Hill-Rom Holdings, Inc., were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2762},"source":{"system":"sec-edgar","filing":"0001214659-21-013220","document":"marketforms-54639.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/47518/000121465921013220/marketforms-54639.xml","form_type":"4"}},{"id":2474765,"issuer":{"id":1707,"kind":"organization","name":"BAXTER INTERNATIONAL INC","symbol":"BAX"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $1 par value","published_at":"2021-12-14T21:10:08.000Z","date":"2021-12-13","kind":"grant","acquired":true,"shares":743,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received a grant of 743 fully vested shares of common stock of Baxter International Inc. subject to the terms and conditions of the applicable grant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person received a grant of 743 fully vested shares of common stock of Baxter International Inc. subject to the terms and conditions of the applicable grant."}],"balance_after":743,"source":{"system":"sec-edgar","filing":"0000899243-21-048121","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10456/000089924321048121/doc4.xml","form_type":"4"}},{"id":2482068,"issuer":{"id":114512,"kind":"organization","name":"Pear Therapeutics, Inc.","symbol":"PEAR"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-07T22:26:03.000Z","date":"2021-12-03","kind":"grant","acquired":true,"shares":110430,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in accordance with the terms of the Business Combination Agreement (the \"Business Combination Agreement\") dated as of June 21, 2021, by and among Thimble Point Acquisition Corp., Oz Merger Sub, Inc. and Pear Therapeutics (US), Inc. (f/k/a Pear Therapeutics, Inc.) (\"Private Pear\"), in exchange for an option to acquire 75,000 shares of common stock of Private Pear for $1.77 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33% of the shares underlying the option vested or shall vest on December 1, 2021, an additional 33% of the shares vested or shall vest on December 1, 2022, and an additional 34% of the shares vested or shall vest on December 1, 2023."}],"balance_after":110430,"derivative":{"exercise_price":1.21,"expiration_date":"2030-12-18","underlying":"Common Stock","underlying_shares":110430},"source":{"system":"sec-edgar","filing":"0001062993-21-012398","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376358/000106299321012398/form4.xml","form_type":"4"}},{"id":2498006,"issuer":{"id":16467,"kind":"organization","name":"Walgreens Boots Alliance, Inc.","symbol":"WBA"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-23T20:04:21.000Z","date":"2021-11-19","kind":"sale","acquired":false,"shares":2725,"price":47.155,"value":128497.375,"ownership":{"direct":true},"balance_after":16570,"source":{"system":"sec-edgar","filing":"0001618921-21-000125","document":"wf-form4_163771584276464.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618921/000161892121000125/wf-form4_163771584276464.xml","form_type":"4"}},{"id":2526280,"issuer":{"id":16467,"kind":"organization","name":"Walgreens Boots Alliance, Inc.","symbol":"WBA"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-03T19:44:30.000Z","date":"2021-11-01","kind":"grant","acquired":true,"shares":4226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan."}],"balance_after":19295,"source":{"system":"sec-edgar","filing":"0001618921-21-000109","document":"wf-form4_163598305440393.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618921/000161892121000109/wf-form4_163598305440393.xml","form_type":"4"}},{"id":2540013,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2021-10-19T13:35:18.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":42,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $67.62. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":10035,"source":{"system":"sec-edgar","filing":"0001127602-21-027259","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760221027259/form4.xml","form_type":"4"}},{"id":2632649,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2021-07-16T18:56:56.000Z","date":"2021-07-15","kind":"grant","acquired":true,"shares":35,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $79.89. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":9993,"source":{"system":"sec-edgar","filing":"0001127602-21-022102","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760221022102/form4.xml","form_type":"4"}},{"id":2721904,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2021-05-10T16:16:21.000Z","date":"2021-05-06","kind":"grant","acquired":true,"shares":1757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan."}],"balance_after":9958,"source":{"system":"sec-edgar","filing":"0001127602-21-015992","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760221015992/form4.xml","form_type":"4"}},{"id":2746316,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2021-04-19T13:50:33.000Z","date":"2021-04-15","kind":"grant","acquired":true,"shares":28,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $82.66. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":8201,"source":{"system":"sec-edgar","filing":"0001127602-21-013959","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760221013959/form4.xml","form_type":"4"}},{"id":2793833,"issuer":{"id":132395,"kind":"organization","name":"Hill-Rom Holdings, Inc.","symbol":"HRC"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Restricted Stock Units (Deferred Stock Award)","published_at":"2021-03-12T16:05:00.000Z","date":"2021-03-11","kind":"grant","acquired":true,"shares":1787,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Restricted stock units are entitled to dividend equivalent rights which accrue on dividend record dates."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company."}],"balance_after":1787,"derivative":{"exercise_price":0,"exercise_date":"2021-03-11","underlying":"Common Stock","underlying_shares":1787},"source":{"system":"sec-edgar","filing":"0000047518-21-000033","document":"wf-form4_161558306988404.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/47518/000004751821000033/wf-form4_161558306988404.xml","form_type":"4"}},{"id":2903590,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2021-01-20T17:41:50.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":28,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2021, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $83.42. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":8173,"source":{"system":"sec-edgar","filing":"0001127602-21-002092","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760221002092/form4.xml","form_type":"4"}},{"id":2996506,"issuer":{"id":16467,"kind":"organization","name":"Walgreens Boots Alliance, Inc.","symbol":"WBA"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-02T16:45:24.000Z","date":"2020-11-01","kind":"grant","acquired":true,"shares":5875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued as non-employee director compensation under the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan."}],"balance_after":15069,"source":{"system":"sec-edgar","filing":"0001618921-20-000128","document":"wf-form4_160435347683307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618921/000161892120000128/wf-form4_160435347683307.xml","form_type":"4"}},{"id":3003430,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2020-10-20T14:42:29.000Z","date":"2020-10-16","kind":"grant","acquired":true,"shares":34,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $68.11. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":8145,"source":{"system":"sec-edgar","filing":"0001127602-20-027250","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760220027250/form4.xml","form_type":"4"}},{"id":3079843,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2020-07-20T21:11:42.000Z","date":"2020-07-16","kind":"grant","acquired":true,"shares":35,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $65.21. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":8111,"source":{"system":"sec-edgar","filing":"0001127602-20-021834","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760220021834/form4.xml","form_type":"4"}},{"id":3158785,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2020-05-07T21:49:55.000Z","date":"2020-05-06","kind":"grant","acquired":true,"shares":2304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan."}],"balance_after":8076,"source":{"system":"sec-edgar","filing":"0001127602-20-015814","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760220015814/form4.xml","form_type":"4"}},{"id":3174788,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2020-04-17T13:18:53.000Z","date":"2020-04-15","kind":"grant","acquired":true,"shares":24,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $69.76. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":5772,"source":{"system":"sec-edgar","filing":"0001127602-20-013962","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760220013962/form4.xml","form_type":"4"}},{"id":3247979,"issuer":{"id":132395,"kind":"organization","name":"Hill-Rom Holdings, Inc.","symbol":"HRC"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Restricted Stock Units (Deferred Stock Award)","published_at":"2020-02-26T16:48:36.000Z","date":"2020-02-26","kind":"grant","acquired":true,"shares":1842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Restricted stock units are entitled to dividend equivalent rights which accrue on dividend record dates."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company."}],"balance_after":1842,"derivative":{"exercise_date":"2020-02-26","underlying":"Common Stock","underlying_shares":1842},"source":{"system":"sec-edgar","filing":"0000047518-20-000032","document":"wf-form4_158275369984759.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/47518/000004751820000032/wf-form4_158275369984759.xml","form_type":"4"}},{"id":3306944,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2020-01-21T14:25:51.000Z","date":"2020-01-16","kind":"grant","acquired":true,"shares":21,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2020, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $77.50. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":5748,"source":{"system":"sec-edgar","filing":"0001127602-20-002001","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760220002001/form4.xml","form_type":"4"}},{"id":3382079,"issuer":{"id":16467,"kind":"organization","name":"Walgreens Boots Alliance, Inc.","symbol":"WBA"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-04T17:41:44.000Z","date":"2019-11-01","kind":"grant","acquired":true,"shares":3485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued as non-employee director compensation under the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan."}],"balance_after":9194,"source":{"system":"sec-edgar","filing":"0001618921-19-000104","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618921/000161892119000104/edgar.xml","form_type":"4"}},{"id":3392535,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2019-10-17T15:27:01.000Z","date":"2019-10-16","kind":"grant","acquired":true,"shares":25,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2019, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $64.71. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":5727,"source":{"system":"sec-edgar","filing":"0001127602-19-030674","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760219030674/form4.xml","form_type":"4"}},{"id":3460353,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2019-07-17T22:16:12.000Z","date":"2019-07-16","kind":"grant","acquired":true,"shares":24,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share and the closing price was $64.39. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":5702,"source":{"system":"sec-edgar","filing":"0001127602-19-024805","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760219024805/form4.xml","form_type":"4"}},{"id":3537134,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2019-05-07T16:04:59.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":2327,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan."}],"balance_after":5678,"source":{"system":"sec-edgar","filing":"0001127602-19-017547","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760219017547/form4.xml","form_type":"4"}},{"id":3550541,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2019-04-24T13:13:40.000Z","date":"2019-04-23","kind":"grant","acquired":true,"shares":15,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share and the closing price was $61.37. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":3351,"source":{"system":"sec-edgar","filing":"0001127602-19-016101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760219016101/form4.xml","form_type":"4"}},{"id":3605502,"issuer":{"id":132395,"kind":"organization","name":"Hill-Rom Holdings, Inc.","symbol":"HRC"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Restricted Stock Units (Deferred Stock Award)","published_at":"2019-03-08T16:27:35.000Z","date":"2019-03-06","kind":"grant","acquired":true,"shares":1722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Restricted stock units are entitled to dividend equivalent rights which accrue on dividend record dates."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company."}],"balance_after":1722,"derivative":{"exercise_date":"2019-03-06","underlying":"Common Stock","underlying_shares":1722},"source":{"system":"sec-edgar","filing":"0000047518-19-000019","document":"wf-form4_155208044144732.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/47518/000004751819000019/wf-form4_155208044144732.xml","form_type":"4"}},{"id":3695027,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2019-01-16T21:12:51.000Z","date":"2019-01-15","kind":"grant","acquired":true,"shares":14,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On January 15, 2019, Encompass Health paid a dividend on its common stock of $0.27 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":3336,"source":{"system":"sec-edgar","filing":"0001127602-19-002130","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760219002130/form4.xml","form_type":"4"}},{"id":3753733,"issuer":{"id":16467,"kind":"organization","name":"Walgreens Boots Alliance, Inc.","symbol":"WBA"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-23T16:01:35.000Z","date":"2018-11-20","kind":"sale","acquired":false,"shares":7050,"price":78.81,"value":555610.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.79 to $78.84, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or any securityholder of the issuer, upon request, information regarding the number of shares sold at each price within the range indicated."}],"balance_after":5709,"source":{"system":"sec-edgar","filing":"0001618921-18-000091","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618921/000161892118000091/edgar.xml","form_type":"4"}},{"id":3775723,"issuer":{"id":16467,"kind":"organization","name":"Walgreens Boots Alliance, Inc.","symbol":"WBA"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-02T17:01:12.000Z","date":"2018-11-01","kind":"grant","acquired":true,"shares":2503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued as non-employee director compensation under the amended and restated Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan."}],"balance_after":12759,"source":{"system":"sec-edgar","filing":"0001618921-18-000083","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618921/000161892118000083/edgar.xml","form_type":"4"}},{"id":3789368,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2018-10-17T20:03:48.000Z","date":"2018-10-15","kind":"grant","acquired":true,"shares":13,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2018, Encompass Health paid a dividend on its common stock of $0.27 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":3322,"source":{"system":"sec-edgar","filing":"0001127602-18-030497","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760218030497/form4.xml","form_type":"4"}},{"id":3865746,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2018-07-18T20:10:20.000Z","date":"2018-07-16","kind":"grant","acquired":true,"shares":12,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units (\"RSUs\") are credited to each non-employee director's account on common stock dividend payment dates. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 16, 2018, Encompass Health paid a dividend on its common stock of $0.25 per share. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment."}],"balance_after":3309,"source":{"system":"sec-edgar","filing":"0001127602-18-023502","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760218023502/form4.xml","form_type":"4"}},{"id":3944897,"issuer":{"id":3460,"kind":"organization","name":"Encompass Health Corp"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true}}],"security":"Encompass Health Common Stock","published_at":"2018-05-07T21:03:09.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":3297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual award of restricted stock units pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan."}],"balance_after":3297,"source":{"system":"sec-edgar","filing":"0001127602-18-016522","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/785161/000112760218016522/form4.xml","form_type":"4"}},{"id":4004700,"issuer":{"id":132395,"kind":"organization","name":"Hill-Rom Holdings, Inc.","symbol":"HRC"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Restricted Stock Units (Deferred Stock Award)","published_at":"2018-03-09T16:59:07.000Z","date":"2018-03-07","kind":"grant","acquired":true,"shares":2116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Restricted stock units are entitled to dividend equivalent rights which accrue on dividend record dates."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company."}],"balance_after":2116,"derivative":{"exercise_date":"2018-03-07","underlying":"Common Stock","underlying_shares":2116},"source":{"system":"sec-edgar","filing":"0000047518-18-000027","document":"wf-form4_152063272110483.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/47518/000004751818000027/wf-form4_152063272110483.xml","form_type":"4"}},{"id":4172784,"issuer":{"id":16467,"kind":"organization","name":"Walgreens Boots Alliance, Inc.","symbol":"WBA"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-03T17:26:40.000Z","date":"2017-11-01","kind":"grant","acquired":true,"shares":2984,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan, as amended."}],"balance_after":10256,"source":{"system":"sec-edgar","filing":"0001618921-17-000097","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618921/000161892117000097/edgar.xml","form_type":"4"}},{"id":4180663,"issuer":{"id":16467,"kind":"organization","name":"Walgreens Boots Alliance, Inc.","symbol":"WBA"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2017-10-25T18:48:16.000Z","date":"2017-10-24","kind":"grant","acquired":true,"shares":445.831,"price":67.29,"value":29999.96799,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The phantom stock is issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan, as amended (including the applicable election forms thereunder, the \"Plan\"), and each unit of phantom stock is the economic equivalent of one share of the company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"To be settled following termination of service as a director in accordance with the terms and conditions of the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"To be settled following termination of service as a director in accordance with the terms and conditions of the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes phantom stock units issued in lieu of dividends (through September 30, 2017) on outstanding phantom stock units."}],"balance_after":55985.2,"derivative":{"underlying":"Common Stock","underlying_shares":445.831},"source":{"system":"sec-edgar","filing":"0001618921-17-000074","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618921/000161892117000074/edgar.xml","form_type":"4"}},{"id":4257770,"issuer":{"id":16467,"kind":"organization","name":"Walgreens Boots Alliance, Inc.","symbol":"WBA"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2017-07-13T17:08:42.000Z","date":"2017-07-12","kind":"grant","acquired":true,"shares":370.872,"price":77.52,"value":28749.99744,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The phantom stock is issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan, as amended (including the applicable election forms thereunder, the \"Plan\"), and each unit of phantom stock is the economic equivalent of one share of the company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"To be settled following termination of service as a director in accordance with the terms and conditions of the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"To be settled following termination of service as a director in accordance with the terms and conditions of the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes phantom stock units issued in lieu of dividends (through June 30, 2017) on outstanding phantom stock units."}],"balance_after":55272.1,"derivative":{"underlying":"Common Stock","underlying_shares":370.872},"source":{"system":"sec-edgar","filing":"0001618921-17-000056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618921/000161892117000056/edgar.xml","form_type":"4"}},{"id":4347713,"issuer":{"id":16467,"kind":"organization","name":"Walgreens Boots Alliance, Inc.","symbol":"WBA"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2017-04-21T16:58:17.000Z","date":"2017-04-20","kind":"grant","acquired":true,"shares":341.692,"price":84.14,"value":28749.96488,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The phantom stock is issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan, as amended (including the applicable election forms thereunder, the \"Plan\"), and each unit of phantom stock is the economic equivalent of one share of the company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"To be settled following termination of service as a director in accordance with the terms and conditions of the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"To be settled following termination of service as a director in accordance with the terms and conditions of the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes phantom stock units issued in lieu of dividends (through March 31, 2017) on outstanding phantom stock units."}],"balance_after":54650.7,"derivative":{"underlying":"Common Stock","underlying_shares":341.692},"source":{"system":"sec-edgar","filing":"0001618921-17-000041","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618921/000161892117000041/edgar.xml","form_type":"4"}},{"id":4383734,"issuer":{"id":132395,"kind":"organization","name":"Hill-Rom Holdings, Inc.","symbol":"HRC"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Employee Restricted Stock Units (Deferred Stock Award)","published_at":"2017-03-16T16:59:46.000Z","date":"2017-03-14","kind":"grant","acquired":true,"shares":2651,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Conversion or exercise price of the restricted stock units is 1-for-1."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Restricted stock units are entitled to dividend equivalent rights which accrue on dividend record dates."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest on the date of grant, however delivery of the underlying shares of common stock will not occur until the later of one year and a day from the date of grant, or the six-month anniversary of the date that the Director ceases to be a member of the Board of Directors of the Company."}],"balance_after":2651,"derivative":{"exercise_date":"2017-03-14","underlying":"Common Stock","underlying_shares":2651},"source":{"system":"sec-edgar","filing":"0000047518-17-000032","document":"wf-form4_148969797124684.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/47518/000004751817000032/wf-form4_148969797124684.xml","form_type":"4"}},{"id":4479289,"issuer":{"id":16467,"kind":"organization","name":"Walgreens Boots Alliance, Inc.","symbol":"WBA"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2017-01-27T17:11:09.000Z","date":"2017-01-26","kind":"grant","acquired":true,"shares":353.759,"price":81.27,"value":28749.99393,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The phantom stock is issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan, as amended (including the applicable election forms thereunder, the \"Plan\"), and each unit of phantom stock is the economic equivalent of one share of the company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"To be settled following termination of service as a director in accordance with the terms and conditions of the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"To be settled following termination of service as a director in accordance with the terms and conditions of the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes phantom stock units issued in lieu of dividends (through January 15, 2017) on outstanding phantom stock units."}],"balance_after":54072.3,"derivative":{"underlying":"Common Stock","underlying_shares":353.759},"source":{"system":"sec-edgar","filing":"0001618921-17-000010","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618921/000161892117000010/edgar.xml","form_type":"4"}},{"id":4567851,"issuer":{"id":16467,"kind":"organization","name":"Walgreens Boots Alliance, Inc.","symbol":"WBA"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-03T17:04:54.000Z","date":"2016-11-01","kind":"grant","acquired":true,"shares":2304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan, as amended."}],"balance_after":7272,"source":{"system":"sec-edgar","filing":"0001618921-16-000087","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618921/000161892116000087/edgar.xml","form_type":"4"}},{"id":4580166,"issuer":{"id":16467,"kind":"organization","name":"Walgreens Boots Alliance, Inc.","symbol":"WBA"},"owners":[{"id":30220,"kind":"person","name":"SCHLICHTING NANCY M","position":1,"cik":"0001376358","reported_name":"SCHLICHTING NANCY M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Units","published_at":"2016-10-13T18:19:22.000Z","date":"2016-10-12","kind":"grant","acquired":true,"shares":367.178,"price":78.3,"value":28750.0374,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The phantom stock is issued as non-employee director compensation under the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan, as amended (including the applicable election forms thereunder, the \"Plan\"), and each unit of phantom stock is the economic equivalent of one share of the company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"To be settled following termination of service as a director in accordance with the terms and conditions of the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"To be settled following termination of service as a director in accordance with the terms and conditions of the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes phantom stock units issued in lieu of dividends (through September 30, 2016) on outstanding phantom stock units."}],"balance_after":53487,"derivative":{"underlying":"Common Stock","underlying_shares":367.178},"source":{"system":"sec-edgar","filing":"0001618921-16-000056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1618921/000161892116000056/edgar.xml","form_type":"4"}}]}